Compile Data Set for Download or QSAR
Report error Found 76 Enz. Inhib. hit(s) with all data for entry = 9785
TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488543(US10954253, Compound 50)
Affinity DataIC50: 2.5nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488544(US10954253, Compound 51)
Affinity DataIC50: 2.80nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488540(US10954253, Compound 52 | US10954253, Compound 47)
Affinity DataIC50: 3nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488542(US10954253, Compound 49)
Affinity DataIC50: 3.10nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488566(US10954253, Compound 73)
Affinity DataIC50: 5.30nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488562(US10954253, Compound 69)
Affinity DataIC50: 5.70nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488541(US10954253, Compound 48)
Affinity DataIC50: 6.30nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488538(US10954253, Compound 45)
Affinity DataIC50: 7.40nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488565(US10954253, Compound 72)
Affinity DataIC50: 8.20nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488556(US10954253, Compound 63)
Affinity DataIC50: 8.30nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488570(US10954253, Compound 77)
Affinity DataIC50: 9nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488557(US10954253, Compound 64)
Affinity DataIC50: 9.90nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488536(US10954253, Compound 43)
Affinity DataIC50: 12.1nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488537(US10954253, Compound 44)
Affinity DataIC50: 12.6nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488560(US10954253, Compound 67)
Affinity DataIC50: 12.8nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488567(US10954253, Compound 74)
Affinity DataIC50: 13nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488569(US10954253, Compound 76)
Affinity DataIC50: 13nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488534(US10954253, Compound 41)
Affinity DataIC50: 13.1nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488522(US10954253, Compound 28)
Affinity DataIC50: 13.2nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488523(US10954253, Compound 29)
Affinity DataIC50: 13.4nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488520(US10954253, Compound 26)
Affinity DataIC50: 14.1nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488553(US10954253, Compound 60)
Affinity DataIC50: 14.8nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488559(US10954253, Compound 66)
Affinity DataIC50: 15nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488525(US10954253, Compound 31)
Affinity DataIC50: 15nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488564(US10954253, Compound 71)
Affinity DataIC50: 15.7nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488554(US10954253, Compound 61)
Affinity DataIC50: 15.7nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488568(US10954253, Compound 75)
Affinity DataIC50: 17nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488535(US10954253, Compound 42)
Affinity DataIC50: 17.4nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488563(US10954253, Compound 70)
Affinity DataIC50: 20.3nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488519(US10954253, Compound 25)
Affinity DataIC50: 20.4nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488531(US10954253, Compound 38)
Affinity DataIC50: 20.7nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488552(US10954253, Compound 59)
Affinity DataIC50: 22.6nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488496(US10954253, Compound 3)
Affinity DataIC50: 24.6nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488521(US10954253, Compound 27)
Affinity DataIC50: 24.9nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488508(US10954253, Compound 12)
Affinity DataIC50: 25.3nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488561(US10954253, Compound 68)
Affinity DataIC50: 30.4nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488533(US10954253, Compound 40)
Affinity DataIC50: 30.7nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488511(US10954253, Compound 15)
Affinity DataIC50: 31.5nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488571(US10954253, Compound 78)
Affinity DataIC50: 32nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488555(US10954253, Compound 62)
Affinity DataIC50: 36.1nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488558(US10954253, Compound 65)
Affinity DataIC50: 41.6nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488509(US10954253, Compound 13)
Affinity DataIC50: 42nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488513(US10954253, Compound 17)
Affinity DataIC50: 42.5nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488572(US10954253, Compound 79)
Affinity DataIC50: 43nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488495(US10954253, Compound 2)
Affinity DataIC50: 43.6nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488539(US10954253, Compound 46)
Affinity DataIC50: 44.6nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488550(US10954253, Compound 57)
Affinity DataIC50: 47nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488510(US10954253, Compound 14)
Affinity DataIC50: 47.8nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488507(US10954253, Compound 11)
Affinity DataIC50: 48.1nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

TargetWee1-like protein kinase(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM488518(US10954253, Compound 24)
Affinity DataIC50: 48.8nMAssay Description:Experimental Reagents:Basic reaction buffer: 20 mM hydroxyethylpiperazine ethanesulfuric acid (pH 7.5), 10 mM magnesium chloride, 1 mM EGTA, 0.02% Br...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: